Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach

Rosen, 1958, Pulmonary alveolar proteinosis, N Engl J Med, 258, 1123, 10.1056/NEJM195806052582301 Tanaka, 1999, Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor, FEBS Lett, 442, 246, 10.1016/S0014-5793(98)01668-8 Suzuki, 2010, Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy, Am J Respir Crit Care Med, 182, 1292, 10.1164/rccm.201002-0271OC Seymour, 2002, Pulmonary alveolar proteinosis: progress in the first 44 years, Am J Respir Crit Care Med, 166, 215, 10.1164/rccm.2109105 Nogee, 2004, Alterations in SP-B and SP-C expression in neonatal lung disease, Annu Rev Physiol, 66, 601, 10.1146/annurev.physiol.66.032102.134711 Wert, 2009, Genetic disorders of surfactant dysfunction, Pediatr Dev Pathol, 12, 253, 10.2350/09-01-0586.1 Hamvas, 2013, Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1, Chest, 144, 794, 10.1378/chest.12-2502 Inoue, 2008, Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan, Am J Respir Crit Care Med, 177, 752, 10.1164/rccm.200708-1271OC Carey, 2010, The molecular basis of pulmonary alveolar proteinosis, Clin Immunol, 135, 223, 10.1016/j.clim.2010.02.017 Serrano, 2006, Protein–lipid interactions and surface activity in the pulmonary surfactant system, Chem Phys Lipids, 141, 105, 10.1016/j.chemphyslip.2006.02.017 Chiba, 2006, Pulmonary surfactant proteins and lipids as modulators of inflammation and innate immunity, Respirology, 11, S2, 10.1111/j.1440-1843.2006.00797.x Kingma, 2006, In defense of the lung: surfactant protein A and surfactant protein D, Curr Opin Pharmacol, 6, 277, 10.1016/j.coph.2006.02.003 Wright, 1990, Clearance and recycling of pulmonary surfactant, Am J Physiol, 259, 1 Dranoff, 1994, Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis, Science, 264, 713, 10.1126/science.8171324 Stanley, 1994, Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology, Proc Natl Acad Sci USA, 91, 5592, 10.1073/pnas.91.12.5592 Robb, 1995, Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5, Proc Natl Acad Sci USA, 92, 9565, 10.1073/pnas.92.21.9565 Huffman, 1996, Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice, J Clin Invest, 97, 649, 10.1172/JCI118461 Reed, 1999, Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice, Am J Physiol, 276, L556 Bonfield, 2003, PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor, Am J Physiol Lung Cell Mol Physiol, 285, L1132, 10.1152/ajplung.00216.2003 Kitamura, 1999, Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor, J Exp Med, 190, 875, 10.1084/jem.190.6.875 Uchida, 2004, High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis, Blood, 103, 1089, 10.1182/blood-2003-05-1565 Kitamura, 2000, Serological diagnosis of idiopathic pulmonary alveolar proteinosis, Am J Respir Crit Care Med, 162, 658, 10.1164/ajrccm.162.2.9910032 Sakagami, 2010, Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates, Am J Respir Crit Care Med, 182, 49, 10.1164/rccm.201001-0008OC Sakagami, 2009, Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis, N Engl J Med, 361, 2679, 10.1056/NEJMc0904077 Thomassen, 2007, ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis, J Lipid Res, 48, 2762, 10.1194/jlr.P700022-JLR200 Baker, 2010, Targeted PPARγ deficiency in alveolar macrophages disrupts surfactant catabolism, J Lipid Res, 51, 1325, 10.1194/jlr.M001651 Sallese, 2017, Targeting cholesterol homeostasis in lung diseases, Sci Rep, 7, 10211, 10.1038/s41598-017-10879-w Christensen, 2000, Role of diminished epithelial GM-CSF in the pathogenesis of bleomycin-induced pulmonary fibrosis, Am J Physiol Lung Cell Mol Physiol, 279, L487, 10.1152/ajplung.2000.279.3.L487 Moore, 2000, GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism, J Immunol, 165, 4032, 10.4049/jimmunol.165.7.4032 Hansen, 2008, The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation, Cell, 134, 496, 10.1016/j.cell.2008.05.053 Shibata, 2001, GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1, Immunity, 15, 557, 10.1016/S1074-7613(01)00218-7 Uchida, 2007, GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis, N Engl J Med, 356, 567, 10.1056/NEJMoa062505 LeVine, 1999, GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection, J Clin Invest, 103, 563, 10.1172/JCI5212 Paine, 2000, Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice, J Immunol, 164, 2602, 10.4049/jimmunol.164.5.2602 Carey, 2007, PU.1 redirects adenovirus to lysosomes in alveolar macrophages, uncoupling internalization from infection, J Immunol, 178, 2440, 10.4049/jimmunol.178.4.2440 Riopel, 2001, Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria, Infect Immun, 69, 129, 10.1128/IAI.69.1.129-136.2001 Rosen, 2015, Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis, Clin Infect Dis, 60, 1017, 10.1093/cid/ciu968 Xipell, 1977, Acute silicoproteinosis, Thorax, 32, 104, 10.1136/thx.32.1.104 Miller, 1984, Pulmonary alveolar proteinosis and aluminum dust exposure, Am Rev Respir Dis, 130, 312, 10.1164/arrd.1984.130.2.312 Cummings, 2012, Indium lung disease, Chest, 141, 1512, 10.1378/chest.11-1880 Zhao, 2015, Whole lung lavage treatment of Chinese patients with autoimmune pulmonary alveolar proteinosis: a retrospective long-term follow-up study, Chin Med J, 128, 2714, 10.4103/0366-6999.167295 Suzuki, 2016, Pulmonary alveolar proteinosis syndrome, Clin Chest Med, 37, 431, 10.1016/j.ccm.2016.04.006 Shah, 2000, Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis, Thorax, 55, 67, 10.1136/thorax.55.1.67 Bonella, 2011, Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients, Respir Med, 105, 1908, 10.1016/j.rmed.2011.08.018 Inoue, 2006, Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan, Respirology, 11, S55, 10.1111/j.1440-1843.2006.00810.x Tokura, 2017, A semiquantitative computed tomographic grading system for evaluating therapeutic response in pulmonary alveolar proteinosis, Ann Am Thorac Soc, 14, 1403, 10.1513/AnnalsATS.201607-574OC Martin, 1978, Pulmonary alveolar proteinosis: shunt fraction and lactic acid dehydrogenase concentration as aids to diagnosis, Am Rev Respir Dis, 117, 1059 Fountain, 1969, Lactate dehydrogenase isoenzymes in alveolar proteinosis, JAMA, 210, 1283, 10.1001/jama.1969.03160330083026 Bonfield, 2002, Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis, Am J Respir Cell Mol Biol, 27, 481, 10.1165/rcmb.2002-0023OC Lin, 2006, Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis, Thorax, 61, 528, 10.1136/thx.2005.054171 Uchida, 2014, Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis, J Immunol Methods, 402, 57, 10.1016/j.jim.2013.11.011 Lin, 2008, Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis, Mayo Clin Proc, 83, 1344, 10.4065/83.12.1344 Bonella, 2013, Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis, Orphanet J Rare Dis, 8, 53, 10.1186/1750-1172-8-53 Seymour, 2003, Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis, Thorax, 58, 252, 10.1136/thorax.58.3.252 Fang, 2013, Elevated tumor markers in patients with pulmonary alveolar proteinosis, Clin Chem Lab Med, 51, 1493, 10.1515/cclm-2012-0738 Arai, 2014, CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis, Respirology, 19, 246, 10.1111/resp.12210 Bonella, 2017, Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis, Respirology, 22, 1371, 10.1111/resp.13082 Ishii, 2009, Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis, Chest, 136, 1348, 10.1378/chest.09-0097 Holbert, 2001, CT features of pulmonary alveolar proteinosis, AJR Am J Roentgenol, 176, 1287, 10.2214/ajr.176.5.1761287 Rossi, 2003, “Crazy-paving” pattern at thin-section CT of the lungs: radiologic-pathologic overview, Radiographics, 23, 1509, 10.1148/rg.236035101 Mehrian, 2014, Features of idiopathic pulmonary alveolar proteinosis in high resolution computed tomography, Pol J Radiol, 79, 65, 10.12659/PJR.890218 Frazier, 2008, From the archives of the AFIP: pulmonary alveolar proteinosis, Radiographics, 28, 883, 10.1148/rg.283075219 Akira, 2016, Pulmonary fibrosis on high-resolution CT of patients with pulmonary alveolar proteinosis, AJR Am J Roentgenol, 207, 544, 10.2214/AJR.15.14982 Burkhalter, 1996, Bronchoalveolar lavage cytology in pulmonary alveolar proteinosis, Am J Clin Pathol, 106, 504, 10.1093/ajcp/106.4.504 Goldstein, 1998, Pulmonary alveolar proteinosis: clinical features and outcomes, Chest, 114, 1357, 10.1378/chest.114.5.1357 Ramirez, 1965, Bronchopulmonary lavage in man, Ann Intern Med, 63, 819, 10.7326/0003-4819-63-5-819 Abdelmalak, 2015, Therapeutic Whole-lung lavage for pulmonary alveolar proteinosis: a procedural update, J Bronchology Interv Pulmonol, 22, 251, 10.1097/LBR.0000000000000180 Cheng, 2002, Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage, Chest, 122, 1480, 10.1378/chest.122.4.1480 Chauhan, 2016, Management of pulmonary alveolar proteinosis with whole lung lavage using extracorporeal membrane oxygenation support in a postrenal transplant patient with graft failure, Ann Card Anaesth, 19, 379, 10.4103/0971-9784.179627 Hasan, 2013, Extracorporeal membrane oxygenation to support whole-lung lavage in pulmonary alveolar proteinosis: salvage of the drowned lungs, J Bronchology Interv Pulmonol, 20, 41, 10.1097/LBR.0b013e31827ccdb5 Bonella, 2012, Wash-out kinetics and efficacy of a modified lavage technique for alveolar proteinosis, Eur Respir J, 40, 1468, 10.1183/09031936.00017612 Campo, 2016, Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures, Orphanet J Rare Dis, 11, 115, 10.1186/s13023-016-0497-9 Gay, 2017, Efficacy of whole-lung lavage in pulmonary alveolar proteinosis: a multicenter international study of GELF, Respiration, 93, 198, 10.1159/000455179 Seymour, 1996, Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis, N Engl J Med, 335, 1924, 10.1056/NEJM199612193352513 Seymour, 2001, Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis, Am J Respir Crit Care Med, 163, 524, 10.1164/ajrccm.163.2.2003146 Venkateshiah, 2006, An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis, Chest, 130, 227, 10.1378/chest.130.1.227 Wylam, 2006, Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis, Eur Respir J, 27, 585, 10.1183/09031936.06.00058305 Tazawa, 2010, Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis, Am J Respir Crit Care Med, 181, 1345, 10.1164/rccm.200906-0978OC Papiris, 2014, Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose, Clin Drug Investig, 34, 553, 10.1007/s40261-014-0208-z Bonfield, 2002, Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis, Clin Immunol, 105, 342, 10.1006/clim.2002.5301 Tazawa, 2014, Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy, Chest, 145, 729, 10.1378/chest.13-0603 Akasaka, 2015, Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study, BMC Pulm Med, 15, 88, 10.1186/s12890-015-0085-0 Linden, 1994, Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF, IL-1 beta, and IL-6, Pulm Pharmacol, 7, 43, 10.1006/pulp.1994.1004 Amital, 2010, Therapeutic effectiveness of rituximab in a patient with unresponsive autoimmune pulmonary alveolar proteinosis, Thorax, 65, 1025, 10.1136/thx.2010.140673 Borie, 2009, Rituximab therapy in autoimmune pulmonary alveolar proteinosis, Eur Respir J, 33, 1503, 10.1183/09031936.00160908 Kavuru, 2011, An open-label trial of rituximab therapy in pulmonary alveolar proteinosis, Eur Respir J, 38, 1361, 10.1183/09031936.00197710 Malur, 2012, Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis, Respir Res, 13, 46, 10.1186/1465-9921-13-46 Luisetti, 2009, Plasmapheresis for treatment of pulmonary alveolar proteinosis, Eur Respir J, 33, 1220, 10.1183/09031936.00097508 Garber, 2015, A plasmapheresis protocol for refractory pulmonary alveolar proteinosis, Lung, 193, 209, 10.1007/s00408-014-9678-2 Jezequel, 2017, Plasmapheresis failure in the treatment of auto-immune pulmonary alveolar proteinosis, Rev Mal Respir, 34, 240 Takaki, 2016, Recurrence of pulmonary alveolar proteinosis after bilateral lung transplantation in a patient with a nonsense mutation in CSF2RB, Respir Med Case Rep, 19, 89 Santamaria, 2004, Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intolerance, J Pediatr, 145, 268, 10.1016/j.jpeds.2004.04.047 Parker, 1997, Recurrent alveolar proteinosis following double lung transplantation, Chest, 111, 1457, 10.1378/chest.111.5.1457 Albores, 2013, A rare occurrence of pulmonary alveolar proteinosis after lung transplantation, Semin Respir Crit Care Med, 34, 431, 10.1055/s-0033-1348472 Philippot, 2017, Secondary pulmonary alveolar proteinosis after lung transplantation: a single-centre series, Eur Respir J, 10.1183/13993003.01369-2016 Kadikoy, 2010, Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus, Nephrol Dial Transplant, 25, 2795, 10.1093/ndt/gfq265 Tokman, 2016, Lung transplant recipient with pulmonary alveolar proteinosis, Case Rep Transplant, 2016, 4628354 Hasan, 2014, Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient, Lung India, 31, 282, 10.4103/0970-2113.135782 Ishii, 2014, Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan, BMC Pulm Med, 14, 37, 10.1186/1471-2466-14-37 Chaulagain, 2014, Secondary pulmonary alveolar proteinosis in hematologic malignancies, Hematol Oncol Stem Cell Ther, 7, 127, 10.1016/j.hemonc.2014.09.003 Nishinakamura, 1996, The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation, J Exp Med, 183, 2657, 10.1084/jem.183.6.2657 Tabata, 2009, Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis, Int J Hematol, 90, 407, 10.1007/s12185-009-0404-4 Kariman, 1984, Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years, Lung, 162, 223, 10.1007/BF02715650 Prakash, 1987, Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review, Mayo Clin Proc, 62, 499, 10.1016/S0025-6196(12)65477-9 Yu, 2014, Whole lung lavage combined with Granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis, BMC Pulm Med, 14, 87, 10.1186/1471-2466-14-87 Yamamoto, 2008, A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis, Pediatr Pulmonol, 43, 828, 10.1002/ppul.20856 Ohkouchi, 2017, Sequential GM-CSF inhalation after whole lung lavage for pulmonary alveolar proteinosis: a report of five intractable cases, Ann Am Thorac Soc, 14, 1298, 10.1513/AnnalsATS.201611-892BC Malur, 2011, Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice, Am J Physiol Lung Cell Mol Physiol, 300, L73, 10.1152/ajplung.00128.2010 Yvan-Charvet, 2010, Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses, Arterioscler Thromb Vasc Biol, 30, 139, 10.1161/ATVBAHA.108.179283 Bonfield, 2008, Peroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factor, J Immunol, 181, 235, 10.4049/jimmunol.181.1.235 Suzuki, 2014, Pulmonary macrophage transplantation therapy, Nature, 514, 450, 10.1038/nature13807 Hetzel, 2017, Function and safety of lentivirus-mediated gene transfer for CSF2RA-deficiency, Hum Gene Ther Methods, 28, 318, 10.1089/hgtb.2017.092 Lachmann, 2014, Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis, Am J Respir Crit Care Med, 189, 167, 10.1164/rccm.201306-1012OC Moodley, 2010, Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair, Am J Respir Crit Care Med, 182, 643, 10.1164/rccm.201001-0014OC Jacob, 2017, Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells, Cell Stem Cell, 21, 472, 10.1016/j.stem.2017.08.014